Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1996 May;40(5):1274–1276. doi: 10.1128/aac.40.5.1274

N-acetylcysteine inhibits germination of conidia and growth of Aspergillus spp. and Fusarium spp.

A J De Lucca 1, T J Walsh 1, D J Daigle 1
PMCID: PMC163307  PMID: 8723482

Abstract

N-Acetylcysteine inhibited hyphal growth and germination of conidia of Aspergillus spp. and Fusarium spp. N-Acetylcysteine inhibited conidial germination as well as or better than L-cysteine. Cysteine-related compounds may provide a potential therapeutic strategy against agriculturally and medically important fungal pathogens.

Full Text

The Full Text of this article is available as a PDF (178.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anaissie E., Kantarjian H., Ro J., Hopfer R., Rolston K., Fainstein V., Bodey G. The emerging role of Fusarium infections in patients with cancer. Medicine (Baltimore) 1988 Mar;67(2):77–83. doi: 10.1097/00005792-198803000-00001. [DOI] [PubMed] [Google Scholar]
  2. Berenguer J., Allende M. C., Lee J. W., Garrett K., Lyman C., Ali N. M., Bacher J., Pizzo P. A., Walsh T. J. Pathogenesis of pulmonary aspergillosis. Granulocytopenia versus cyclosporine and methylprednisolone-induced immunosuppression. Am J Respir Crit Care Med. 1995 Sep;152(3):1079–1086. doi: 10.1164/ajrccm.152.3.7663787. [DOI] [PubMed] [Google Scholar]
  3. Borgström L., Kågedal B., Paulsen O. Pharmacokinetics of N-acetylcysteine in man. Eur J Clin Pharmacol. 1986;31(2):217–222. doi: 10.1007/BF00606662. [DOI] [PubMed] [Google Scholar]
  4. Denning D. W., Stevens D. A. Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases. Rev Infect Dis. 1990 Nov-Dec;12(6):1147–1201. doi: 10.1093/clinids/12.6.1147. [DOI] [PubMed] [Google Scholar]
  5. Diamond G., Zasloff M., Eck H., Brasseur M., Maloy W. L., Bevins C. L. Tracheal antimicrobial peptide, a cysteine-rich peptide from mammalian tracheal mucosa: peptide isolation and cloning of a cDNA. Proc Natl Acad Sci U S A. 1991 May 1;88(9):3952–3956. doi: 10.1073/pnas.88.9.3952. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Dutkiewicz J., Olenchock S. A., Sorenson W. G., Gerencser V. F., May J. J., Pratt D. S., Robinson V. A. Levels of bacteria, fungi, and endotoxin in bulk and aerosolized corn silage. Appl Environ Microbiol. 1989 May;55(5):1093–1099. doi: 10.1128/aem.55.5.1093-1099.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Espinel-Ingroff A., Dawson K., Pfaller M., Anaissie E., Breslin B., Dixon D., Fothergill A., Paetznick V., Peter J., Rinaldi M. Comparative and collaborative evaluation of standardization of antifungal susceptibility testing for filamentous fungi. Antimicrob Agents Chemother. 1995 Feb;39(2):314–319. doi: 10.1128/aac.39.2.314. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kramer M. N., Kurup V. P., Fink J. N. Allergic bronchopulmonary aspergillosis from a contaminated dump site. Am Rev Respir Dis. 1989 Oct;140(4):1086–1088. doi: 10.1164/ajrccm/140.4.1086. [DOI] [PubMed] [Google Scholar]
  9. Lortholary O., Meyohas M. C., Dupont B., Cadranel J., Salmon-Ceron D., Peyramond D., Simonin D. Invasive aspergillosis in patients with acquired immunodeficiency syndrome: report of 33 cases. French Cooperative Study Group on Aspergillosis in AIDS. Am J Med. 1993 Aug;95(2):177–187. doi: 10.1016/0002-9343(93)90258-q. [DOI] [PubMed] [Google Scholar]
  10. Maayan C., Bar-Yishay E., Yaacobi T., Marcus Y., Katznelson D., Yahav Y., Godfrey S. Immediate effect of various treatments on lung function in infants with cystic fibrosis. Respiration. 1989;55(3):144–151. doi: 10.1159/000195725. [DOI] [PubMed] [Google Scholar]
  11. Merz W. G., Karp J. E., Hoagland M., Jett-Goheen M., Junkins J. M., Hood A. F. Diagnosis and successful treatment of fusariosis in the compromised host. J Infect Dis. 1988 Nov;158(5):1046–1055. doi: 10.1093/infdis/158.5.1046. [DOI] [PubMed] [Google Scholar]
  12. Mullins J., Harvey R., Seaton A. Sources and incidence of airborne Aspergillus fumigatus (Fres). Clin Allergy. 1976 May;6(3):209–217. doi: 10.1111/j.1365-2222.1976.tb01899.x. [DOI] [PubMed] [Google Scholar]
  13. Nelson P. E., Dignani M. C., Anaissie E. J. Taxonomy, biology, and clinical aspects of Fusarium species. Clin Microbiol Rev. 1994 Oct;7(4):479–504. doi: 10.1128/cmr.7.4.479. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Oddera S., Silvestri M., Sacco O., Eftimiadi C., Rossi G. A. N-acetylcysteine enhances in vitro the intracellular killing of Staphylococcus aureus by human alveolar macrophages and blood polymorphonuclear leukocytes and partially protects phagocytes from self-killing. J Lab Clin Med. 1994 Aug;124(2):293–301. [PubMed] [Google Scholar]
  15. Ohman L., Dahlgren C., Follin P., Lew D., Stendahl O. N-acetylcysteine enhances receptor-mediated phagocytosis by human neutrophils. Agents Actions. 1992 Jul;36(3-4):271–277. [PubMed] [Google Scholar]
  16. Pannuti C., Gingrich R., Pfaller M. A., Kao C., Wenzel R. P. Nosocomial pneumonia in patients having bone marrow transplant. Attributable mortality and risk factors. Cancer. 1992 Jun 1;69(11):2653–2662. doi: 10.1002/1097-0142(19920601)69:11<2653::aid-cncr2820691106>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  17. Pursell K. J., Telzak E. E., Armstrong D. Aspergillus species colonization and invasive disease in patients with AIDS. Clin Infect Dis. 1992 Jan;14(1):141–148. doi: 10.1093/clinids/14.1.141. [DOI] [PubMed] [Google Scholar]
  18. REAS H. W. THE USE OF N-ACETYLCYSTEINE IN THE TREATMENT OF CYSTIC FIBROSIS. J Pediatr. 1964 Oct;65:542–557. doi: 10.1016/s0022-3476(64)80289-4. [DOI] [PubMed] [Google Scholar]
  19. Riise G. C., Larsson S., Larsson P., Jeansson S., Andersson B. A. The intrabronchial microbial flora in chronic bronchitis patients: a target for N-acetylcysteine therapy? Eur Respir J. 1994 Jan;7(1):94–101. doi: 10.1183/09031936.94.07010094. [DOI] [PubMed] [Google Scholar]
  20. Rylander R. Organic dusts and lung reactions--exposure characteristics and mechanisms for disease. Scand J Work Environ Health. 1985 Jun;11(3 Spec No):199–206. doi: 10.5271/sjweh.2234. [DOI] [PubMed] [Google Scholar]
  21. Schaffner A., Douglas H., Braude A. Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus. Observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes. J Clin Invest. 1982 Mar;69(3):617–631. doi: 10.1172/JCI110489. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Vincken W., Roels P. Hypersensitivity pneumonitis due to Aspergillus fumigatus in compost. Thorax. 1984 Jan;39(1):74–75. doi: 10.1136/thx.39.1.74. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Walsh T. J., Dixon D. M. Nosocomial aspergillosis: environmental microbiology, hospital epidemiology, diagnosis and treatment. Eur J Epidemiol. 1989 Jun;5(2):131–142. doi: 10.1007/BF00156818. [DOI] [PubMed] [Google Scholar]
  24. Walsh T. J. Invasive pulmonary aspergillosis in patients with neoplastic diseases. Semin Respir Infect. 1990 Jun;5(2):111–122. [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES